Ana Milinkovic
Overview
Explore the profile of Ana Milinkovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
834
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iwuji C, Waters L, Milinkovic A, Orkin C, Fox J, Post F, et al.
Virol J
. 2025 Feb;
22(1):33.
PMID: 39930490
Background: There are limited data on how historical nucleoside reverse transcriptase inhibitor (NRTI) resistance-associated mutations (RAMs) other than M184V/I, affect the activity of B/F/TAF. We evaluated the outcomes of switching...
2.
Garcia-Diez A, Porta-Vilaro M, Isern-Kebschull J, Naude N, Guggenberger R, Brugnara L, et al.
Quant Imaging Med Surg
. 2024 Nov;
14(11):7937-7957.
PMID: 39544479
Myosteatosis has emerged as an important concept in muscle health as it is associated with an increased risk of adverse health outcomes, a higher rate of complications, and increased mortality...
3.
Whitlock G, Fidler S, Clarke A, Kang S, Xhikola A, Milinkovic A, et al.
HIV Res Clin Pract
. 2024 Sep;
25(1):2400453.
PMID: 39244669
Background: Head-to-head data for bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF; B) and darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DRV/c/F/TAF; D) are lacking in the context of rapid antiretroviral therapy (ART) initiation. This study, BIC-T&T, evaluates the efficacy...
4.
Morup S, Leung P, Reilly C, Sherman B, Chang W, Milojevic M, et al.
AIDS Res Ther
. 2024 May;
21(1):27.
PMID: 38698440
Background: Human genetic contribution to HIV progression remains inadequately explained. The type 1 interferon (IFN) pathway is important for host control of HIV and variation in type 1 IFN genes...
5.
Batterham R, Bedimo R, Diaz R, Guaraldi G, Lo J, Martinez E, et al.
J Antimicrob Chemother
. 2024 Apr;
79(6):1218-1233.
PMID: 38656584
Objectives: To develop consensus data statements and clinical recommendations to provide guidance for improving cardiometabolic health outcomes in people with HIV based on the knowledge and experience of an international...
6.
Paredes J, Arenas-Pinto A, McAlpine C, Matthews R, Milinkovic A, Suonpera E
AIDS Care
. 2024 Jan;
36(10):1392-1399.
PMID: 38289649
Contemporary evidence is needed to assess whether the prevalence of depression remains high among people living with HIV in the United Kingdom despite recent efforts to improve patients' mental health,...
7.
Moore A, Burns J, Sally D, Milinkovic A, Krokos G, John J, et al.
AIDS
. 2023 Dec;
38(4):521-529.
PMID: 38061030
Objective: Bone loss in people with HIV (PWH) is poorly understood. Switching tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) has yielded bone mineral density (BMD) increases. PETRAM (NCT#:03405012) investigated...
8.
Sullivan A, Saunders J, Desai M, Cartier A, Mitchell H, Jaffer S, et al.
Lancet HIV
. 2023 Dec;
10(12):e790-e806.
PMID: 38040478
Background: HIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV acquisition. To enable routine commissioning of PrEP in England, we aimed to establish population need, duration of need, PrEP...
9.
OHalloran C, Gilleece Y, Leung S, Canuto V, McAlpine C, Ross S, et al.
Int J STD AIDS
. 2023 Nov;
35(3):206-216.
PMID: 37970812
Background: Doravirine is a non-nucleoside reverse transcriptase inhibitor recommended for the treatment of virologically suppressed and treatment naïve people living with HIV. The DRIVE-REAL study aimed to describe the characteristics,...
10.
Vrbic M, Milinkovic A
Front Aging
. 2023 Oct;
4:1260053.
PMID: 37780864
The immune-inflammatory response is the basis of the pathophysiology of SARS-Cov-2 infection. In severe cases of COVID-19 uncontrolled systemic inflammatory response causes multiorgan dysfunction (MODS), as the most common immediate...